• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断痛风患者心血管事件的短期风险

Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout.

作者信息

Cipolletta Edoardo, Nakafero Georgina, Richette Pascal, Avery Anthony J, Mamas Mamas A, Tata Laila J, Abhishek Abhishek

机构信息

University of Nottingham, Nottingham, United Kingdom, and Polytechnic University of Marche, Ancona, Italy.

University of Nottingham, Nottingham, United Kingdom.

出版信息

Arthritis Rheumatol. 2025 Feb;77(2):202-211. doi: 10.1002/art.42986. Epub 2024 Oct 17.

DOI:10.1002/art.42986
PMID:39279144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782110/
Abstract

OBJECTIVE

To investigate the temporal association between the first diagnosis of gout and cardiovascular events in the short term.

METHODS

We performed a self-controlled case series analysis and a cohort study using data from linked primary care, hospitalization, and mortality records from the United Kingdom's Clinical Practice Research Database-GOLD. We included individuals with a new diagnosis of gout either in the primary care or secondary care between January 1, 1997 and December 31, 2020. The first consultation at which gout was diagnosed was the exposure of interest. The main outcome consisted of cardiovascular events (ie, a composite of fatal and nonfatal myocardial infarction, ischemic or hemorrhagic stroke, and transient ischemic attack).

RESULTS

The 4,398 patients (66.9% male, mean age 74.6 years) had a cardiovascular event within at least two years of their first recorded diagnosis of gout. The incidence of cardiovascular events was significantly higher in the 30 days after the first diagnosis of gout compared to baseline (adjusted incidence rate ratio 1.55, 95% confidence interval [CI] 1.33-1.83). Among 76,440 patients (72.9% male, mean age 63.2 years) included in the cohort study, the incidence of cardiovascular events in the 30 days after the first gout diagnosis (31.2 events per 1,000 person-years, 95% CI 27.1-35.9) was significantly higher than in days 31 to 730 after gout diagnosis (21.6 events per 1,000 person-years, 95% CI 20.8-22.4) with a rate difference of -9.6 events per 1,000 person-years (95% CI -14.0 to -5.1).

CONCLUSION

Individuals had a short-term increased risk of cardiovascular events in the 30 days following the first consultation at which gout was diagnosed.

摘要

目的

调查痛风首次诊断与短期内心血管事件之间的时间关联。

方法

我们使用来自英国临床实践研究数据库-GOLD的关联初级保健、住院和死亡记录数据进行了一项自我对照病例系列分析和一项队列研究。我们纳入了1997年1月1日至2020年12月31日期间在初级保健或二级保健中首次诊断为痛风的个体。诊断痛风的首次会诊是感兴趣的暴露因素。主要结局包括心血管事件(即致命和非致命心肌梗死、缺血性或出血性中风以及短暂性脑缺血发作的综合)。

结果

4398例患者(66.9%为男性,平均年龄74.6岁)在首次记录诊断痛风后的至少两年内发生了心血管事件。与基线相比,痛风首次诊断后30天内心血管事件的发生率显著更高(调整后的发病率比为1.55,95%置信区间[CI]为1.33-1.83)。在队列研究纳入的76440例患者(72.9%为男性,平均年龄63.2岁)中,痛风首次诊断后30天内心血管事件的发生率(每1000人年31.2例事件,95%CI为27.1-35.9)显著高于痛风诊断后31至730天(每1000人年21.6例事件,95%CI为20.8-22.4),率差为每1000人年-9.6例事件(95%CI为-14.0至-5.1)。

结论

在诊断痛风的首次会诊后的30天内,个体发生心血管事件的短期风险增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/cc752c0d22f5/ART-77-202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/82e8f0b09ef9/ART-77-202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/a61d5e6c14a5/ART-77-202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/0e970f1e1339/ART-77-202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/cc752c0d22f5/ART-77-202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/82e8f0b09ef9/ART-77-202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/a61d5e6c14a5/ART-77-202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/0e970f1e1339/ART-77-202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5485/11782110/cc752c0d22f5/ART-77-202-g002.jpg

相似文献

1
Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout.新诊断痛风患者心血管事件的短期风险
Arthritis Rheumatol. 2025 Feb;77(2):202-211. doi: 10.1002/art.42986. Epub 2024 Oct 17.
2
Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.痛风患者痛风发作与随后心血管事件的关系。
JAMA. 2022 Aug 2;328(5):440-450. doi: 10.1001/jama.2022.11390.
3
Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data.痛风患者在开始使用或不使用秋水仙碱预防发作的降尿酸治疗时的心血管事件:一项使用初级保健、住院和死亡率关联数据的回顾性新用户队列研究。
Lancet Rheumatol. 2025 Mar;7(3):e197-e207. doi: 10.1016/S2665-9913(24)00248-0. Epub 2024 Dec 18.
4
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study.别嘌醇与非布司他治疗痛风患者的心血管风险比较:一项全国性队列研究。
Rheumatology (Oxford). 2019 Dec 1;58(12):2122-2129. doi: 10.1093/rheumatology/kez189.
5
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.别嘌醇治疗缺血性心脏病患者的心血管结局:ALL-HEART RCT 及经济学评价。
Health Technol Assess. 2024 Mar;28(18):1-55. doi: 10.3310/ATTM4092.
6
Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies.四项基于人群的队列研究中参与者的脑出血与随后的动脉缺血性事件之间的关联。
JAMA Neurol. 2021 Jul 1;78(7):809-816. doi: 10.1001/jamaneurol.2021.0925.
7
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.评估起始用非布司他与别嘌醇治疗老年痛风患者的心血管风险:基于人群的队列研究。
Circulation. 2018 Sep 11;138(11):1116-1126. doi: 10.1161/CIRCULATIONAHA.118.033992.
8
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.德国、英国、美国和法国确诊痛风的试验对照患者的合并症负担:一项回顾性分析。
Adv Ther. 2016 Jul;33(7):1180-98. doi: 10.1007/s12325-016-0346-1. Epub 2016 May 26.
9
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.痛风和糖尿病患者使用别嘌醇与急性心血管事件风险
BMC Cardiovasc Disord. 2017 Mar 14;17(1):76. doi: 10.1186/s12872-017-0513-6.
10
Prognosis of undiagnosed chest pain: linked electronic health record cohort study.未确诊胸痛的预后:关联电子健康记录队列研究
BMJ. 2017 Apr 3;357:j1194. doi: 10.1136/bmj.j1194.

引用本文的文献

1
Acute Coronary Syndrome and Rheumatic Disease.急性冠状动脉综合征与风湿性疾病
J Clin Med. 2025 Feb 23;14(5):1490. doi: 10.3390/jcm14051490.
2
Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.痛风与高尿酸血症:关于其合并症及临床意义的叙述性综述
J Clin Med. 2024 Dec 13;13(24):7616. doi: 10.3390/jcm13247616.

本文引用的文献

1
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls.痛风与 12 种心血管疾病发病风险:一项包含 152663 例痛风患者和 709981 例匹配对照的病例对照研究。
Lancet Rheumatol. 2024 Mar;6(3):e156-e167. doi: 10.1016/S2665-9913(23)00338-7.
2
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.痛风患者发作期、间歇期和达标治疗期的系统性炎症细胞因子谱:TNFSF14 作为新的生物标志物。
Ann Rheum Dis. 2024 Jun 12;83(7):945-956. doi: 10.1136/ard-2023-225305.
3
Serum Urate and Recurrent Gout.
血清尿酸与复发性痛风
JAMA. 2024 Feb 6;331(5):417-424. doi: 10.1001/jama.2023.26640.
4
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial.评价秋水仙碱与泼尼松在老年急性焦磷酸钙结晶关节炎患者中的安全性和短期等效性(COLCHICORT):一项开放标签、多中心、随机试验。
Lancet Rheumatol. 2023 Sep;5(9):e523-e531. doi: 10.1016/S2665-9913(23)00165-0. Epub 2023 Aug 8.
5
Inflammation and cardiovascular disease: new epidemiologic data and their potential implications for anti-cytokine therapy.炎症与心血管疾病:新的流行病学数据及其对抗细胞因子治疗的潜在影响。
Eur J Prev Cardiol. 2023 Nov 9;30(16):1728-1730. doi: 10.1093/eurjpc/zwad251.
6
Filling gaps in female gout: a cross-sectional study of comorbidities in 192 037 hospitalised patients.填补女性痛风研究空白:192037 例住院患者共病的横断面研究。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003191.
7
Risk of Major Adverse Cardiovascular Event Following Incident Hospitalization for Acute Gout: A Western Australian Population-Level Linked Data Study.急性痛风首次住院后发生主要不良心血管事件的风险:一项西澳大利亚州基于人群的关联数据研究。
ACR Open Rheumatol. 2023 Jun;5(6):298-304. doi: 10.1002/acr2.11540. Epub 2023 May 11.
8
Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis.预测性糖蛋白乙酰化水平与考虑血清尿酸水平的新发和复发 flares 风险:一项基于人群的前瞻性研究和孟德尔随机化分析。
Arthritis Rheumatol. 2023 Sep;75(9):1648-1657. doi: 10.1002/art.42523. Epub 2023 Jul 12.
9
Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study.严重感染与心血管疾病风险:一项多队列研究。
Circulation. 2023 May 23;147(21):1582-1593. doi: 10.1161/CIRCULATIONAHA.122.061183. Epub 2023 Mar 27.
10
Risk of Venous Thromboembolism With Gout Flares.痛风发作与静脉血栓栓塞风险。
Arthritis Rheumatol. 2023 Sep;75(9):1638-1647. doi: 10.1002/art.42480. Epub 2023 Jun 15.